DE3750719D1 - Material aus karboxylgruppen enthaltenden polysacchariden, sowie verfahren zur herstellung solcher polysaccharide. - Google Patents

Material aus karboxylgruppen enthaltenden polysacchariden, sowie verfahren zur herstellung solcher polysaccharide.

Info

Publication number
DE3750719D1
DE3750719D1 DE3750719T DE3750719T DE3750719D1 DE 3750719 D1 DE3750719 D1 DE 3750719D1 DE 3750719 T DE3750719 T DE 3750719T DE 3750719 T DE3750719 T DE 3750719T DE 3750719 D1 DE3750719 D1 DE 3750719D1
Authority
DE
Germany
Prior art keywords
polysaccharides
pct
production
carboxyl groups
containing carboxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3750719T
Other languages
English (en)
Other versions
DE3750719T2 (de
Inventor
Tomas Maelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Biosurgery Inc
Original Assignee
Biomatrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomatrix Inc filed Critical Biomatrix Inc
Publication of DE3750719D1 publication Critical patent/DE3750719D1/de
Application granted granted Critical
Publication of DE3750719T2 publication Critical patent/DE3750719T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/005—Crosslinking of cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0033—Xanthan, i.e. D-glucose, D-mannose and D-glucuronic acid units, saubstituted with acetate and pyruvate, with a main chain of (beta-1,4)-D-glucose units; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
DE3750719T 1986-06-18 1987-06-09 Material aus karboxylgruppen enthaltenden polysacchariden, sowie verfahren zur herstellung solcher polysaccharide. Expired - Lifetime DE3750719T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8602705A SE452469B (sv) 1986-06-18 1986-06-18 Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
PCT/SE1987/000272 WO1987007898A1 (en) 1986-06-18 1987-06-09 Material of polysaccharides containing carboxyl groups, and a process for producing such polysaccharides

Publications (2)

Publication Number Publication Date
DE3750719D1 true DE3750719D1 (de) 1994-12-08
DE3750719T2 DE3750719T2 (de) 1995-05-11

Family

ID=20364848

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750719T Expired - Lifetime DE3750719T2 (de) 1986-06-18 1987-06-09 Material aus karboxylgruppen enthaltenden polysacchariden, sowie verfahren zur herstellung solcher polysaccharide.

Country Status (8)

Country Link
US (1) US4963666A (de)
EP (1) EP0272300B1 (de)
JP (1) JPH07116242B2 (de)
AT (1) ATE113609T1 (de)
DE (1) DE3750719T2 (de)
HK (1) HK1003227A1 (de)
SE (1) SE452469B (de)
WO (1) WO1987007898A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5209626A (en) * 1986-01-22 1993-05-11 Computer Aided Systems, Inc. Organizer system for a rotatable storage structure
US5147861A (en) * 1986-06-30 1992-09-15 Fidia S.P.A. Esters of alginic acid
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
EP0784487A1 (de) * 1993-03-19 1997-07-23 Medinvent Ein präparat und ein verfahren zur gewebevermehrung
JP3404557B2 (ja) * 1993-09-30 2003-05-12 グンゼ株式会社 架橋ヒアルロン酸及びこれらの複合材料
US5502042A (en) 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US5677276A (en) * 1994-12-23 1997-10-14 La Jolla Cancer Research Foundation Immobilization of peptides to hyaluronate
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
US6123957A (en) * 1997-07-16 2000-09-26 Jernberg; Gary R. Delivery of agents and method for regeneration of periodontal tissues
EP1140229B1 (de) * 1998-12-16 2010-10-06 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Saure superabsorbierende polysaccharide
GB9902412D0 (en) * 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
WO2000051566A1 (en) 1999-03-04 2000-09-08 United States Surgical Corporation Scar reduction
CA2337187C (en) 1999-05-29 2011-02-22 Guanghui Zhang Bioabsorbable blends and surgical articles therefrom
CA2390556C (en) 1999-11-09 2009-05-19 Denki Kagaku Kogyo Kabushiki Kaisha Use of soluble cellulose derivative having been made hardly soluble in water and method for producing it
TW574301B (en) * 2001-05-02 2004-02-01 Ind Tech Res Inst Manufacturing method of epoxide crosslinked polysaccharides matrix
US20040235791A1 (en) * 2002-01-25 2004-11-25 Gruskin Elliott A. Scar reduction
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
AU2003901834A0 (en) * 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
JP2004323454A (ja) * 2003-04-25 2004-11-18 Chisso Corp 薬剤
CN1829743B (zh) * 2003-07-30 2010-06-30 安特易斯有限公司 生物医用的复合基质
DE10343413A1 (de) * 2003-09-19 2005-04-14 Universität Hamburg Vernetzte, langzeitstabile Carboxymethylstärke als Absorptionsmittel für Wasser, deren Verwendung sowie Verfahren zu deren Herstellung
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
GB0329907D0 (en) * 2003-12-23 2004-01-28 Innomed Ltd Compositions
WO2005113608A1 (en) * 2004-05-20 2005-12-01 Mentor Corporation Method of covalently linking hyaluronan and chitosan
CA2567532C (en) * 2004-05-20 2013-10-01 Mentor Corporation Methods for making injectable polymer hydrogels
WO2008088830A2 (en) * 2007-01-16 2008-07-24 Evolved Nanomaterial Sciences, Inc. Chiral separating agents with active support
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
EP2313008B1 (de) 2008-07-18 2017-04-12 Wake Forest University Health Sciences Vorrichtung zur herzgewebemodulation mittels topischer anwendung von vakuum zur minimierung von zelltod und -beschädigung
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
LT2742070T (lt) * 2011-08-10 2021-10-25 Glycores 2000 Srl Degradacijai atsparus tinklinis mažos molekulinės masės hialuronatas
KR101240518B1 (ko) 2012-03-26 2013-03-11 주식회사 제네웰 생체 적합성 고분자를 이용한 이식용 재료
ITMI20120732A1 (it) 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
RU2689559C2 (ru) * 2013-06-28 2019-05-28 Гальдерма С.А. Способ получения продукта из поперечно-сшитой гиалуроновой кислоты
ES2653549T3 (es) 2013-09-30 2018-02-07 Galderma S.A. Funcionalización y reticulación de ácido hialurónico en un paso
CN117915933A (zh) 2021-09-01 2024-04-19 上海其胜生物制剂有限公司 使用含有软骨细胞或干细胞的可注射可原位聚合胶原组合物进行软骨再生

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE169293C1 (de) * 1958-03-13 1959-11-10
US3042667A (en) * 1959-03-10 1962-07-03 Pharmacia Ab Process for producing dextran derivatives and products resulting therefrom
CH445129A (fr) * 1964-04-29 1967-10-15 Nestle Sa Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
US4076930A (en) * 1968-12-13 1978-02-28 James Ellingboe Polysaccharide polyols
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
JPS55134646A (en) * 1979-04-06 1980-10-20 Kureha Chem Ind Co Ltd Amphoteric ion exchanger
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
SE437270B (sv) * 1983-07-19 1985-02-18 Pharmacia Ab Separationsmaterial av tverbunden agaros och dess framstellning separationsmaterial av tverbunden agaros och dess framstellning
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
SE456346B (sv) * 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
CS249368B1 (en) * 1984-12-29 1987-03-12 Jan Peska Method of pearls detran materials production for gel chromatography
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
SE453394B (sv) * 1986-07-07 1988-02-01 Pharmacia Ab Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen

Also Published As

Publication number Publication date
WO1987007898A1 (en) 1987-12-30
JPH07116242B2 (ja) 1995-12-13
HK1003227A1 (en) 1998-10-16
ATE113609T1 (de) 1994-11-15
EP0272300A1 (de) 1988-06-29
JPS63503551A (ja) 1988-12-22
SE452469B (sv) 1987-11-30
DE3750719T2 (de) 1995-05-11
US4963666A (en) 1990-10-16
SE8602705D0 (sv) 1986-06-18
EP0272300B1 (de) 1994-11-02

Similar Documents

Publication Publication Date Title
DE3750719D1 (de) Material aus karboxylgruppen enthaltenden polysacchariden, sowie verfahren zur herstellung solcher polysaccharide.
DE3485447D1 (de) Verfahren und zusammensetzungen zur herstellung von phenylalanin.
DE3882011T2 (de) Verfahren und Vorrichtung zur Herstellung von Biopolymer-Einkristall.
DE3381586D1 (de) Verfahren zur herstellung von dispersionsverfestigten metallkoerpern sowie diese koerper.
DE69109301T2 (de) Verfahren zur herstellung von polyhydroxyfettsäureamiden in gegenwart von lösungsmitteln.
DE69003063D1 (de) Verfahren zur herstellung von sulfonylimiden.
DE68904291D1 (de) Verfahren zur herstellung von geliermittel-suesswaren.
DE3789881D1 (de) Verfahren zur Herstellung von Photomasken und Photomaske.
DE3784162T2 (de) Funktioneller film und verfahren zur herstellung.
DE3786785T2 (de) Verfahren zur herstellung von mos-bauelementen für integrierte schaltungen.
AT363469B (de) Verfahren zur herstellung von 3,4,5,6-tetrahydro-2h-1-benzoxocinen und 6a,10a-cis-hexahydrodibenzo(b,d)pyran-9-onen
DE69810735T2 (de) Zusammensetzung für die Behandlung von Wasser und deren Verfahren zur Herstellung
DE3878090D1 (de) Verfahren zur herstellung von supraleitenden schaltungen.
DE3684922D1 (de) Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden.
DE69009697D1 (de) Gegenstand für die transdermale Applikation von Estradiol und Verfahren zur Herstellung eines solchen Gegenstandes.
AT360379B (de) Verfahren zur herstellung von stiefeln u.dgl. aus plastikmaterial und danach hergestellter stiefel
DE3770224D1 (de) Verfahren zur herstellung von hypofluoriten und bis-hypofluoriten.
DE3777556D1 (de) Verfahren zur herstellung von in elektronischen teilen verwendeter keramik.
DE69020135T2 (de) Konvergierender filter und verfahren zur herstellung.
DE3766046D1 (de) Verfahren zur herstellung von isopropylakohol und tertiaeren c4-bis c5-alkoholen.
DE3851062T2 (de) Verfahren und zusammensetzung zur härtung von gelatinezusammensetzungen.
DE69110295T2 (de) Verfahren zur herstellung von iminen und/oder aminen von alkoholen.
DE59103949D1 (de) Verfahren zur Herstellung von Leder und Pelzen.
DE3484398D1 (de) Verfahren zur herstellung von benzthiazolen.
DE3774049D1 (de) Verfahren zur trennung von maltose aus zusammensetzungen von maltose mit glukose und anderen sacchariden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GENZYME BIOSURGERY CORPORATION, CAMBRIDGE, MASS.,